News | December 15, 2022
LG Chem inks deal with Innovent Biologics for gout treatment candidate
LG Chem will receive totaling up to $95.5 million for the China rights
LG Chem will receive totaling up to $95.5 million for the China rights
India is home to nearly 80 million diabetics and this number is expected to rise to a staggering 134 million in the next 25 years.
Phase III trial also demonstrated a statistically significant reduction (14%) in hospitalization for any cause, bringing potential relief for patients and reducing burden on healthcare systems
Man lost 54 Kgs in 6 months with MGB procedure
Younger Indians have a 10 times higher rate of heart attack
NADMED technology is based on proprietary extraction and the individual measurement of NAD metabolites
48% of people are either hypertensive or at risk of becoming hypertensive & 30% of people have a high Waist Hip Ratio (WHR) – an early indication of the onset of CVDs
82.5% of patients treated at 10mg dose of obicetrapib achieved LDL-c target of <70 mg/dL, compared to 20% of patients treated with placebo
To address the preventive & primary healthcare delivery gaps in India
Follows Zealand Pharma’s appointment of Adam Steensberg as CEO and decision to refocus strategy
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
